Totally agree but what impresses me more is the compassionate...

First 6 Last

Share
Profile

Follow
saggito

616 Posts.

58

01/03/18

22:02

Post #: 31465324
Share

Originally posted by Stayso 54 ↑

Thanks slammer

Just as a side note, I think we will all be happy to view the attached link. Some may recall that I have posted this on previous occasions. It shows that at the close of ASX trading today, Dr Kelly and the management team lead a company that has delivered the best return to shareholders compared with all other companies first listed in the same year (2016). To my knowledge, 27 February 2018 is a first for Noxopharm in this regard.

All I can say is wow, wow wow. As RBx has commented, this further validates placing our trust in Dr Kelly.

However, these kinds of things of course are subject to change in very short order. They are obviously pleasing as shareholders but perhaps as a caution, we shouldn't dwell on this for much more than a moment - one red wine maybe.

But what strikes me is this. Dr Kelly has rid himself of cancer. He looks, acts and is driven like a man with a mission more than half his age. Yet he could have simply walked away at that point and sought about enjoying a comfortable retirement with his delightful wife and family.

But no. Not this man.

As a result of his selflessness, Dr Kelly has assembled a team and a range of products that on this day has delivered a windfall for NOX shareholders and the real hope for cancer sufferers that he will achieve for them what he has done for himself.

As far as we know, one individual under the compassionate program has already experienced this.

And this is all before any DARRT interim or otherwise results become known.

As Dr Kelly leaves for ESMO, I note that from a weather perspective that the 'Beast from the East' weather system is bearing down towards Paris.

Dr Kelly has proven his toughness already. I'm betting that even in potentially minus twenty on the streets of the french capital that this nasty weather system will be little match.

I raise my glass. Plenty more to be done but hats off thus far.

Expand

Totally agree but what impresses me more is the compassionate program, only open to late stage patients when other treatments have failed. Confidence in the treatment must be sky high. Huge upside if results positive.

NOX Price at posting: $1.40 Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

HotCopper Highlights: Your most watched stocks for Week 48, 2024

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

First 6 Last

Add NOX (ASX) to my watchlist

(20min delay)
Last 9.9¢		Change 0.000(0.00%)		Mkt cap ! $29.22M

Open	High	Low	Value	Volume
10.0¢	10.5¢	9.9¢	$4.773K	48.10K

Buyers (Bids)

No.	Vol.	Price($)
1	20574	9.9¢

Sellers (Offers)

Price($)	Vol.	No.
11.0¢	38542	2

View Market Depth

No.	Vol.	Price($)
5	620344	0.110
1	9523	0.105
5	149890	0.100
1	25357	0.098
2	176978	0.096

Price($)	Vol.	No.
0.120	106914	1
0.125	128094	1
0.130	166171	3
0.135	199760	1
0.140	230213	8

Last trade - 16.10pm 29/11/2024 (20 minute delay)

NOX (ASX) Chart

Totally agree but what impresses me more is the compassionate...

Top Stories

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Buyers (Bids)

Sellers (Offers)